Core Concept - Kingsford® has launched the "Pass The Tongs" initiative in Atlanta to celebrate Black grilling traditions and empower future grillers through culture, education, and community connection [1][3]. Group 1: Initiative Overview - "Pass The Tongs" is part of Kingsford's mission to preserve barbecue traditions and support future changemakers, having invested over $355,000 in the barbecue community since 2021 through its "Preserve the Pit" initiative [3]. - The initiative includes partnerships with Historically Black Colleges and Universities (HBCUs) and local organizations to highlight stories and traditions that have influenced generations [3][4]. Group 2: Events and Activities - The initiative will feature a series of events in Atlanta, starting with a Greek grill-off and smokehouse sampling at the Atlanta Greek Picnic [5][6]. - Upcoming events include "Morehouse Hump Wednesday" on August 27, featuring curated grill tastings and discussions on cultural preservation, and "Taste of Soul Atlanta" on August 30, showcasing regional barbecue styles [8]. Group 3: Company Background - Kingsford, founded over 100 years ago, is recognized as America's favorite charcoal brand, maintaining its production in the USA with both North American and global ingredients [7]. - The brand is synonymous with the authentic experience of charcoal grilling, catering to a diverse audience from novice grillers to professional chefs [7].

Group 1 - Consumer staples stocks are recognized for their reliability in dividend payments, making them attractive for investors seeking consistent returns [1] - The demand for everyday products remains stable even during economic downturns, reinforcing the appeal of the consumer staples industry [1] - TQP Research employs a value-oriented investment strategy, focusing on businesses that align with long-term success principles advocated by renowned investors like Warren Buffett and Charlie Munger [1] Group 2 - Investment topics covered by TQP Research include market analysis, macroeconomic trends, large-cap blue chip companies, and undervalued micro-cap and small-cap stocks [1] - The firm actively engages with the community, encouraging questions and ideas from members [1]

Core Viewpoint - The article discusses the importance of selecting companies with solid fundamentals that can sustain dividend increases, contrasting them with companies that may overpay dividends temporarily to attract investors [1][2]. Group 1: Clorox Co. (NYSE: CLX) - Clorox has a current dividend yield of 3.97% with an annual dividend of $4.96 and a dividend payout ratio of 76.07% [4][5]. - The stock has fallen to 72% of its 52-week high, making its attractive dividend payout more appealing [4]. - Clorox's latest quarterly earnings showed a net EPS of $2.87, significantly beating the expected $2.24, indicating potential for higher future valuations [7]. Group 2: Wells Fargo & Co. (NYSE: WFC) - Wells Fargo has a dividend yield of 2.06% with an annual dividend of $1.60 and a payout ratio of 27.40% [9]. - The bank's management has increased its dividend payout to $1.80 per share, reflecting confidence in future earnings as the market anticipates lower interest rates [11]. - Analysts expect Wells Fargo's EPS to rise to $1.73 for Q2 2026, a 12% increase from the current $1.54 [10]. Group 3: Sunoco LP (NYSE: SUN) - Sunoco offers a high dividend yield of 6.89% with an annual dividend of $3.59 and a payout ratio of 176.85% [13]. - The company has increased its dividend payout to $3.63 per share, providing an annualized yield of 6.68% [14]. - Analysts have rated Sunoco as a Buy, with a target price of $67 per share, suggesting a potential upside of 25% from current trading levels [15].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 10-K ☑ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended June 30, 2025 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________to__________. Commission file number: 1-07151 THE CLOROX COMPANY (Exact name of registrant as specified in its charter) Delaware 31 ...

Financial Performance - The Clorox Company has published its financial data for fiscal Q4 2025 and the entire FY 2025, along with an outlook for FY 2026 [1] Analyst Perspective - The analyst previously assigned a "sell" rating to Clorox approximately one year ago, indicating a negative outlook on the company's performance [1] Investment Strategy - The article emphasizes the importance of dividend investing as a pathway to financial freedom, suggesting that it is an accessible method for building long-term wealth [1]

Core Insights - Clorox reported a significant increase in adjusted EPS to $2.87, surpassing analyst expectations of $2.20, with GAAP revenue reaching $1.99 billion, exceeding the forecast of $1.93 billion [1][2] - The strong performance was primarily driven by one-time "incremental ERP shipments" ahead of a digital system upgrade, which is not expected to recur [1][5] - Management anticipates lower sales and profits for FY2026, projecting a decline in net sales by 6% to 10% and adjusted EPS down by 18% to 23% [1][10] Financial Performance - Adjusted EPS increased by 57.7% year-over-year from $1.82 in Q4 2024 to $2.87 in Q4 2025 [2] - GAAP revenue grew by 4.7% year-over-year from $1.90 billion in Q4 2024 to $1.99 billion in Q4 2025 [2] - Operating cash flow increased by 41% in FY2025, reaching $981 million, while cash and equivalents declined to $167 million as of June 30, 2025 [6] Segment Performance - Health & Wellness segment net sales grew by 14%, with adjusted EBIT increasing by 20% [7] - Household segment net sales rose by 7%, with EBIT jumping 59%, both inflated by one-time volume surges [7] - Lifestyle segment net sales increased by 3%, reflecting innovation and reduced advertising [7] Strategic Focus - Clorox is prioritizing brand equity, supply chain management, product innovation, and digital transformation [4] - The company is investing over $570 million in digital technology to modernize operations and improve analytics [9] - Corporate responsibility and sustainability efforts, including waste and emissions reduction, are key components of the company's strategy [4] Future Outlook - Management expects organic sales to decline by 5% to 9% in FY2026, with gross margin compressing by 50 to 100 basis points [10] - The company faces $100 million in annualized cost pressure from new import tariffs starting in early FY2026 [9] - Investors will monitor Clorox's ability to manage inventory normalization, tariff impacts, and shifts in consumer behavior [11]

Core Insights - The Clorox Company (CLX) reported strong fourth-quarter fiscal 2025 results, with both revenue and earnings exceeding expectations and showing year-over-year growth [1][3][4] - The company is advancing its long-term strategy with the rollout of a new U.S. enterprise resource planning (ERP) system aimed at enhancing growth and efficiency [2][15] Financial Performance - Adjusted earnings per share (EPS) reached $2.87, surpassing the Zacks Consensus Estimate of $2.24, marking a 57.7% increase from $1.82 in the same quarter last year [3] - Net sales totaled $1.99 billion, a 4.5% increase year-over-year, driven by an 8-point increase in volume, partially offset by a 4-point decline in price mix [4] - Organic sales grew by 8% year-over-year [4] Segment Performance - The Health and Wellness segment saw a 14% increase in sales to $741 million, driven by an 18-point increase in volume [6] - The Household segment reported a 7% increase in net sales to $639 million, with a 13-point increase in volume [7] - The Lifestyle segment's sales grew by 3% to $339 million, reflecting an 8-point increase in volume [8] - The International segment experienced a 1% decline in net sales to $269 million, despite a 5-point increase in volume [9] Gross Profit and Margins - Gross profit increased by 4.5% year-over-year to $924 million, with a gross margin remaining flat at 46.5% [5] - Incremental ERP shipments contributed approximately 150 basis points to gross margin [5] Future Guidance - For fiscal 2026, net sales are expected to decline by 6% to 10%, with organic sales anticipated to decrease by 5% to 9% due to the reversal of incremental shipments from the previous year [16][19] - Adjusted EPS is projected to be between $5.95 and $6.30, indicating a decline of 18% to 23% from the previous year [20]

来源：格隆汇APP 格隆汇8月1日｜高乐氏公布截至6月30日的2025财年Q4业绩，营收同比增长4%至20亿美元，高于分析 师预期的19.4亿美元；调整后每股盈利2.87美元，亦高过预期的2.21美元；毛利率为46.5%，与去年同期 基本持平。高乐氏对今年7月开始的2026财年的展望低于预期，因为公司关键营运软件转换，导致零售 商订单大幅减少，估计将对未来一年的盈利造成高达每股95美仙的负面影响。公司预计2026财年净销售 额将同比下降6%至10%，每股盈利将介乎5.95至6.3美元，低于预期。 ...

Core Insights - Clorox reported revenue of $1.99 billion for the quarter ended June 2025, reflecting a 4.5% increase year-over-year and a surprise of +3.04% over the Zacks Consensus Estimate of $1.93 billion [1] - Earnings per share (EPS) reached $2.87, significantly higher than the $1.82 reported in the same quarter last year, resulting in an EPS surprise of +28.12% compared to the consensus estimate of $2.24 [1] Financial Performance Metrics - Organic Revenue Growth in Health and Wellness was 14%, exceeding the average estimate of 6.3% from four analysts [4] - Organic Revenue Growth in International markets was 1%, slightly below the average estimate of 2.4% [4] - Organic Revenue Growth in Lifestyle was 3%, compared to the average estimate of 6.3% [4] - Organic Revenue Growth in Household products was 7%, surpassing the average estimate of 4.6% [4] - Overall Organic Sales Growth was 8%, above the average estimate of 5.4% [4] Revenue Breakdown - Net Revenue for Health and Wellness was $741 million, exceeding the average estimate of $692.86 million, representing a year-over-year increase of +13.7% [4] - Net Revenue for International markets was $269 million, slightly below the average estimate of $249.98 million, with a year-over-year change of -0.7% [4] - Net Revenue for Lifestyle products was $339 million, compared to the average estimate of $349.59 million, reflecting a +3.4% year-over-year change [4] - Net Revenue for Household products was $639 million, above the average estimate of $626.55 million, indicating a +7% year-over-year increase [4] Income Before Taxes - Income before income taxes for Health and Wellness was $243 million, surpassing the average estimate of $219.1 million [4] - Income before income taxes for Corporate and Other segments was -$56 million, worse than the average estimate of -$26.67 million [4] - Income before income taxes for International markets was $23 million, slightly above the average estimate of $21.21 million [4]

Core Insights - Clorox reported quarterly earnings of $2.87 per share, exceeding the Zacks Consensus Estimate of $2.24 per share, and showing a significant increase from $1.82 per share a year ago, resulting in an earnings surprise of +28.12% [1] - The company achieved revenues of $1.99 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.04% and reflecting a year-over-year increase from $1.9 billion [2] - Clorox shares have underperformed the market, losing approximately 22.3% since the beginning of the year, while the S&P 500 has gained 8.2% [3] Earnings Outlook - The future performance of Clorox's stock will largely depend on management's commentary during the earnings call and the revisions of earnings estimates [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.47 on revenues of $1.59 billion, and for the current fiscal year, it is $6.39 on revenues of $6.86 billion [7] Industry Context - The Consumer Products - Staples industry, to which Clorox belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5]